BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23536483)

  • 1. Prevention of de novo hepatitis B with adefovir plus vaccination in recipients of liver transplants from core antibody-positive donors.
    Chang MS; Olsen SK; Pichardo EM; Heese S; Stiles JB; Guarrera JV; Emond JC; Brown RS
    Liver Transpl; 2013 Apr; 19(4):462. PubMed ID: 23536483
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
    Chang MS; Olsen SK; Pichardo EM; Stiles JB; Rosenthal-Cogan L; Brubaker WD; Guarrera JV; Emond JC; Brown RS
    Transplantation; 2013 Apr; 95(7):960-5. PubMed ID: 23545507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B.
    Tan J; Lok AS
    Liver Transpl; 2007 Mar; 13(3):323-6. PubMed ID: 17318864
    [No Abstract]   [Full Text] [Related]  

  • 4. Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.
    Yaşar DG; Suyanı E; Özenirler S; Sucak GT
    Transplant Proc; 2013 Mar; 45(2):833-4. PubMed ID: 23498831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
    Veroux M; Corona D; Ekser B; Giaquinta A; Tallarita T; De Martino C; Gentile F; Virgilio C; Gagliano M; Fiamingo P; Veroux P
    Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
    Schiff E; Lai CL; Hadziyannis S; Neuhaus P; Terrault N; Colombo M; Tillmann H; Samuel D; Zeuzem S; Villeneuve JP; Arterburn S; Borroto-Esoda K; Brosgart C; Chuck S;
    Liver Transpl; 2007 Mar; 13(3):349-60. PubMed ID: 17326221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donors.
    Chang MS; Olsen SK; Pichardo EM; Heese S; Stiles JB; Abdelmessih R; Verna EC; Guarrera JV; Emond JC; Brown RS
    Liver Transpl; 2012 Jul; 18(7):834-8. PubMed ID: 22422699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments.
    Yap DY; Tang CS; Yung S; Choy BY; Yuen MF; Chan TM
    Transplantation; 2010 Aug; 90(3):325-30. PubMed ID: 20562676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B.
    Fung J; Chan SC; Cheung C; Yuen MF; Chok KS; Sharr W; Chan AC; Cheung TT; Seto WK; Fan ST; Lai CL; Lo CM
    Am J Gastroenterol; 2013 Jun; 108(6):942-8. PubMed ID: 23629601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.
    Lau GK; Cooksley H; Ribeiro RM; Powers KA; Shudo E; Bowden S; Hui CK; Anderson J; Sorbel J; Mondou E; Rousseau F; Lewin S; Perelson AS; Locornini S; Naoumov NV
    Antivir Ther; 2007; 12(5):705-18. PubMed ID: 17713154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of adefovir monotherapy in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infected patients.
    Gelinck LB; Claas EC; Kroon FP
    J Hepatol; 2005 Aug; 43(2):360-1; author reply 361. PubMed ID: 15970350
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study.
    Liaw YF; Raptopoulou-Gigi M; Cheinquer H; Sarin SK; Tanwandee T; Leung N; Peng CY; Myers RP; Brown RS; Jeffers L; Tsai N; Bialkowska J; Tang S; Beebe S; Cooney E
    Hepatology; 2011 Jul; 54(1):91-100. PubMed ID: 21503940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus with primary resistance to adefovir.
    Chang TT; Lai CL
    N Engl J Med; 2006 Jul; 355(3):322-3; author reply 323. PubMed ID: 16855278
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
    Lu JJ; Liu K; Ma YJ; Wang J; Chen EQ; Tang H
    J Viral Hepat; 2013 Apr; 20 Suppl 1():40-5. PubMed ID: 23458523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute hepatitis B: is antiviral therapy indicated? Two case reports].
    Girke J; Wedemeyer H; Wiegand J; Manns MP; Tillmann HL
    Dtsch Med Wochenschr; 2008 May; 133(22):1178-82. PubMed ID: 18491273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis Among Hepatitis B Core Antibody-positive Deceased-donor Liver Transplant Recipients: Hepatitis B Immunoglobulin Plus Oral Antiviral Agents Versus Antiviral Agents Alone: A Single-center Experience.
    Malik MU; Ucbilek E; Trilianos P; Cameron AM; Gurakar A
    Exp Clin Transplant; 2017 Apr; 15(2):183-188. PubMed ID: 27212251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of lamivudine-resistant hepatitis B infection in post-renal transplant patients with adefovir dipivoxil: preliminary results.
    de Silva HJ; Dassanayake AS; Manamperi A; de Silva AP
    Transplant Proc; 2006 Nov; 38(9):3118-20. PubMed ID: 17112914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T-cell responses in chronic hepatitis B patients treated with nucleos(t)ide analogs compared with healthy subjects and untreated infected individuals.
    Chen LY; Zhu LY; Yang BS; Bi MR; Yan BZ; Wang W; Ma YJ
    Hepatogastroenterology; 2012; 59(120):2582-6. PubMed ID: 22626879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of de novo hepatitis B virus infections: more seems no better.
    Mutimer D
    Liver Transpl; 2010 Mar; 16(3):256-8. PubMed ID: 20209586
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of kidney donors with hepatitis B, hepatitis C, or brain tumor: a single-center experience.
    Tatar E; Turan MN; Firat O; Sezer TO; Sozbilen M; Solak I; Toz H; Hoscoskun C
    Transplant Proc; 2012; 44(6):1601-3. PubMed ID: 22841224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.